John Dingell News
Most Popular John Dingell Story
FDA probes Vytorin cancer risk
Yesterday, a study appeared to clear statins of their possible link to cancer. But today, the FDA says it's... Read more...
Latest Headlines
- December 11, 2008
- November 21, 2008
- November 10, 2008
- September 29, 2008
- September 19, 2008
- August 22, 2008
- August 1, 2008
- July 31, 2008
- July 30, 2008
- July 24, 2008
- July 18, 2008
- June 26, 2008
- June 17, 2008
- May 21, 2008
- April 23, 2008
- April 22, 2008
- April 21, 2008
- April 18, 2008
- April 18, 2008
- April 14, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
